Peak Financial Advisors LLC Makes New $2.30 Million Investment in UnitedHealth Group Incorporated $UNH

Key Points

• Peak Financial Advisors LLC invested approximately $2.30 million in UnitedHealth Group, acquiring 7,368 shares, based on recent SEC filings.
• UnitedHealth Group announced a quarterly dividend of $2.21 per share, set to be paid on September 23rd, with a 2.5% dividend yield.
• The company's latest earnings report showed a miss on EPS estimates, earning $4.08 against a consensus of $4.45, while revenue rose by 12.9% year-over-year.

Peak Financial Advisors LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 7,368 shares of the healthcare conglomerate's stock, valued at approximately $2,299,000.

Several other large investors have also recently added to or reduced their stakes in the business. Bayforest Capital Ltd increased its stake in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its position in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares in the last quarter. Copia Wealth Management acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $42,000. IAG Wealth Partners LLC acquired a new position in UnitedHealth Group in the first quarter worth approximately $42,000. Finally, Investment Management Corp VA ADV acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at $44,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.1%

Shares of NYSE UNH traded up $0.36 during mid-day trading on Wednesday, reaching $340.14. 3,635,260 shares of the company traded hands, compared to its average volume of 13,011,745. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company's fifty day moving average is $293.51 and its two-hundred day moving average is $367.23. The stock has a market cap of $308.05 billion, a PE ratio of 14.71, a price-to-earnings-growth ratio of 2.27 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. JPMorgan Chase & Co. reduced their target price on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. Oppenheimer reduced their price objective on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Barclays boosted their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research report on Thursday, September 4th. Finally, Royal Bank Of Canada lowered their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.